Sung‐Ling Tang

Statistics

Publications

Citations

102

H-Index

Active since

2014

Affiliations

National Defense Medical Center(Current)

Tri-Service General Hospital

National Taiwan University of Science and Technology

China Medical University

Taipei Medical University Hospital

Sung‐Ling Tang is an author at National Defense Medical Center specializing in chitosan nanocarriers, nanoparticle drug delivery, and nanoparticle formulations.

ORCID

Publications per year

2014–2022

Publications

Characterization and anti-tumor effects of chondroitin sulfate–chitosan nanoparticles delivery system

Chieh-Shen Hu, Sung‐Ling Tang, Chiao‐Hsi Chiang et al. · Journal of Nanoparticle Research · 2014 · 46 citations

Pharmacy, Molecular Pharmaceutics, Pharmaceutics +12

Transcriptomic-Based Identification of the Immuno-Oncogenic Signature of Cholangiocarcinoma for HLC-018 Multi-Target Therapy Exploration

Bashir Lawal, Yu-Cheng Kuo, Sung‐Ling Tang et al. · Cells · 2021 · 27 citations · Full text

Medicine, Molecular Biology, Oncology +17

Evaluation of Chitosan Derivative Microparticles Encapsulating Superparamagnetic Iron Oxide and Doxorubicin as a pH-Sensitive Delivery Carrier in Hepatic Carcinoma Treatment: An in vitro Comparison Study

Meng‐Yi Bai, Sung‐Ling Tang, Meng-Han Chuang et al. · Frontiers in Pharmacology · 2018 · 19 citations · Full text

Pharmacy, Molecular Pharmaceutics, Pharmaceutics +17

Anticancer Activities of 9-chloro-6-(piperazin-1-yl)-11H-indeno[1,2-c] quinolin-11-one (SJ10) in Glioblastoma Multiforme (GBM) Chemoradioresistant Cell Cycle-Related Oncogenic Signatures

Ntlotlang Mokgautsi, Yu‐Cheng Kuo, Sung‐Ling Tang et al. · Cancers · 2022 · 10 citations · Full text

Medicine, Oncology, Pharmacology +17

1–4 of 4